Bipolar disorder drugs market is anticipated to grow at a significant CAGR during the forecast period . The primary factor attributable to the market growth includes the rising cases of bipolar disorder all over the globe. Adding to this, the underlying cause of bipolarity such as high stress, substance abuse, and others, have also grown among the global population. As a matter of fact, with the shifting perspective of the global population toward mental health, there is an increased demand for diagnosis and treatment of various mental disorders. Bipolar disorder, being one such prevalent issue, is thus anticipated to spur its drugs market. As per the Institute for Health Metrics and Evaluation (IHME), Global Burden of Diseases, the prevalence of bipolar disorder across the world varies from 0.3 to 1.2% by country.
In 2017 around 46 million people in the world had bipolar disorder, with 52% and 48% being female and male, respectively. The typical age of onset is the late teens or the early 20s, and a history of depression is common in people diagnosed with bipolar. Although contrary to the general misconception, the possibility of men and women being affected by bipolar disorder is similar. Thus, the surge in the cases of the disease among females as well as males coupled with the rising need to manage the disease effectively is projected to lead to the growth of the market. As a measure to increase the awareness about mental disorders and depression, growing initiatives by the government institutes, are further anticipated to rise in the future years.
To Request a Sample of our Report on Bipolar Disorder Drugs Market: https://www.omrglobal.com/request-sample/bipolar-disorder-drugs-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
- Segment Covered-
- By Drug Class
- Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape: GlaxoSmithKline plc, Pfizer Inc., and AbbVie Inc., among others.
Bipolar Disorder Drugs Market Report by Segment
By Drug Class
- Mood Stabilizers
- Antipsychotic
- Antidepressant
- Antianxiety
A full Report of Bipolar Disorder Drugs Market is Available @ https://www.omrglobal.com/industry-reports/bipolar-disorder-drugs-market
Bipolar Disorder Drugs Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
